Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q4 2025 ▲▼ | Q1 2026 ▲▼ | Change ▲▼ | Q4 2025 ▲▼ | Q1 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Maze Therapeutics, Inc.(MAZE) | 4,120,053 | 4,120,053 | 0 | $170.69M | $122.98M | 18.16% | -$47.71M |
| Rapport Therapeutics, Inc.(RAPP) | 3,728,738 | 3,728,738 | 0 | $113.13M | $116.67M | 17.23% | +$3.54M |
| Vir Biotechnology, Inc.(VIR) | 12,916,663 | 12,916,663 | 0 | $77.89M | $115.73M | 17.09% | +$37.85M |
| Erasca, Inc.(ERAS) | 11,055,554 | 7,091,557 | -3,963,997 | $41.13M | $114.74M | 16.95% | +$73.61M |
| Beam Therapeutics Inc.(BEAM) | 4,540,132 | 4,540,132 | 0 | $125.85M | $108.19M | 15.98% | -$17.66M |
| Lyell Immunopharma, Inc.(LYEL) | 2,759,072 | 3,247,162 | +488,090 | $84.92M | $65.14M | 9.62% | -$19.79M |
| Generate Biomedicines, Inc.(GENB) | 0 | 1,944,426 | +1,944,426 | $0 | $24.31M | 3.59% | +$24.31M |
| 10x Genomics, Inc.CL A(TXG) | 737,539 | 217,834 | -519,705 | $12.03M | $4.62M | 0.68% | -$7.40M |
| Gossamer Bio, Inc.(GOSS) | 8,055,916 | 8,055,916 | 0 | $24.97M | $2.65M | 0.39% | -$22.33M |
| Q32 Bio Inc.(QTTB) | 320,482 | 320,482 | 0 | $1.06M | $2.06M | 0.30% | +$993.5K |